ALEXANDRE LAPILLONNE to United States Food and Drug Administration
This is a "connection" page, showing publications ALEXANDRE LAPILLONNE has written about United States Food and Drug Administration.
Connection Strength
0.213
-
Reevaluating the FDA's warning against the use of probiotics in preterm neonates: A societal statement by ESPGHAN and EFCNI. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1403-1408.
Score: 0.213
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.